Literature DB >> 16152610

Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas.

Flávio J Pimenta1, Dawidson A Gomes, Paolla F Perdigão, Alvimar A Barbosa, Marco A Romano-Silva, Marcus V Gomez, C Marcelo Aldaz, Luiz De Marco, Ricardo S Gomez.   

Abstract

Oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm of the oral cavity, representing 90% of all oral carcinomas and accounting for 3-5% of all malignancies. The WWOX gene (WW-domain containing oxidoreductase) is a candidate tumor suppressor gene located at 16q23.3-24.1, spanning the second most common fragile site, FRA16D. In this report, the role of the WWOX gene was investigated in 20 tumors and 10 normal oral mucosas, and we demonstrated an altered WWOX gene in 50% (10/20) of OSCCs. Using nested RT-PCR, mRNA transcription was altered in 35% of the tumors, with the complete absence of transcripts in 2 samples as well as absence of exons 6-8 (2 tumors), exon 7 (1 tumor), exon 7 and exon 6-8 (1 tumor) and partial loss of exons 8 and 9 (1 tumor). To determine if the aberrant transcripts were translated, Western blots were performed in all samples; however, only the normal protein was detected. By immunohistochemistry, a reduction in Wwox protein expression was observed, affecting 40% of the tumors when compared with normal mucosa. In addition, a novel somatic mutation (S329F) was found. The presence of alterations in mRNA transcription correlated with the reduced expression of Wwox protein in the tumors. These results show that the WWOX gene is frequently altered in OSCC and may contribute to the carcinogenesis processes in oral cancer. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16152610      PMCID: PMC4145845          DOI: 10.1002/ijc.21446

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer.

Authors:  J A Maier; P Voulalas; D Roeder; T Maciag
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

3.  Role of FHIT in human cancer.

Authors:  C M Croce; G Sozzi; K Huebner
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

4.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

5.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

6.  WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.

Authors:  Sai Yendamuri; Tamotsu Kuroki; Francesco Trapasso; Adam C Henry; Kristoffel R Dumon; Kay Huebner; Noel N Williams; Larry R Kaiser; Carlo M Croce
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

7.  Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.

Authors:  Laura A Kresty; Susan R Mallery; Thomas J Knobloch; Huijuan Song; Mary Lloyd; Bruce C Casto; Christopher M Weghorst
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

8.  Association between gene expression profile and tumor invasion in oral squamous cell carcinoma.

Authors:  Gokce A Toruner; Celal Ulger; Mualla Alkan; Anthony T Galante; Joseph Rinaggio; Randall Wilk; Bin Tian; Patricia Soteropoulos; Meera R Hameed; Marvin N Schwalb; James J Dermody
Journal:  Cancer Genet Cytogenet       Date:  2004-10-01

9.  The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.

Authors:  Tamotsu Kuroki; Sai Yendamuri; Francesco Trapasso; Ayumi Matsuyama; Rami I Aqeilan; Hansjuerg Alder; Shashi Rattan; Rossano Cesari; Maria L Nolli; Noel N Williams; Masaki Mori; Takashi Kanematsu; Carlo M Croce
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

10.  Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.

Authors:  Tamotsu Kuroki; Francesco Trapasso; Takeshi Shiraishi; Hansjuerg Alder; Koshi Mimori; Masaki Mori; Carlo M Croce
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

View more
  18 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

2.  WWOX protein expression in normal human tissues.

Authors:  Maria I Nunez; John Ludes-Meyers; C Marcelo Aldaz
Journal:  J Mol Histol       Date:  2006-08-29       Impact factor: 2.611

3.  WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC).

Authors:  Onur Baykara; Ahmet Demirkaya; Kamil Kaynak; Serhan Tanju; Alper Toker; Nur Buyru
Journal:  Tumour Biol       Date:  2010-05-18

Review 4.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

5.  Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma.

Authors:  Wei Yang; Xiao-Ming Wang; Hong-Yan Yuan; Zhi-Hui Liu; Shuang Gao; Liang Peng
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

6.  Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours.

Authors:  D Ramos; M Abba; J A López-Guerrero; J Rubio; E Solsona; S Almenar; A Llombart-Bosch; C M Aldaz
Journal:  Histopathology       Date:  2008-04-29       Impact factor: 5.087

7.  The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

Authors:  Ileana Aderca; Catherine D Moser; Manivannan Veerasamy; Ahmad H Bani-Hani; Ruben Bonilla-Guerrero; Kadra Ahmed; Abdirashid Shire; Sophie C Cazanave; Damian P Montoya; Teresa A Mettler; Lawrence J Burgart; David M Nagorney; Stephen N Thibodeau; Julie M Cunningham; Jin-Ping Lai; Lewis R Roberts
Journal:  J Hepatol       Date:  2008-06-09       Impact factor: 25.083

8.  Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias.

Authors:  Flávio Juliano Pimenta; Gabriela Tavares Cordeiro; Luiz Gustavo Garcia Santos Pimenta; Michelle Beatriz Viana; Joyce Lopes; Marcus Vinícius Gomez; C Marcelo Aldaz; Luiz De Marco; Ricardo Santiago Gomez
Journal:  Oral Oncol       Date:  2007-12-03       Impact factor: 5.337

9.  Targeted deletion of Wwox reveals a tumor suppressor function.

Authors:  Rami I Aqeilan; Francesco Trapasso; Sadiq Hussain; Stefan Costinean; Dean Marshall; Yuri Pekarsky; John P Hagan; Nicola Zanesi; Mohamed Kaou; Gary S Stein; Jane B Lian; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

10.  Association between decreased WWOX protein expression and thyroid cancer development.

Authors:  Eduardo P Dias; Flavio J Pimenta; Marta S Sarquis; Marco A Dias Filho; C M Aldaz; Julienne B Fujii; Ricardo S Gomez; Luiz De Marco
Journal:  Thyroid       Date:  2007-11       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.